| Views | |
|---|---|
| (1 R,3 S)-3-(1 H -Benzo[ d ]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient | 120 |
| August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|
| (1 R,3 S)-3-(1 H -Benzo[ d ]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient | 2 | 27 | 10 | 14 | 6 | 8 |
| Views | |
|---|---|
| Chuev_H_Benzo.pdf | 52 |
| Views | |
|---|---|
| United States | 51 |
| Canada | 13 |
| Romania | 5 |
| Russia | 5 |
| Brazil | 3 |
| Australia | 2 |
| India | 2 |
| Vietnam | 2 |
| Chile | 1 |
| China | 1 |
| Views | |
|---|---|
| Houston | 14 |
| San Francisco | 12 |
| Ottawa | 11 |
| Galati | 5 |
| Dearborn | 3 |
| Mount Laurel | 2 |
| Yekaterinburg | 2 |
| Amman | 1 |
| Ann Arbor | 1 |
| Asheville | 1 |